Pfizer is ready to seek U.S. authorization for a third dose of its coronavirus vaccine, outlining Thursday a top up shot within 12 months could dramatically boost immunity and counter any virus mutant.

Pfizer’s Dr. Mikael Dolsten told the Associated Press early data from the company’s booster study suggests people’s antibody levels rise five- to 10-fold after a third dose, compared to their second dose months earlier.

In April, Pfizer flagged plans to ask the Food and Drug Administration (FDA) for emergency authorization of a third dose, as Breitbart News reported.

“We believe that the third dose will raise the antibody response 10- to 20- fold,” Pfizer CEO Albert Bourla said at the time, likening it to the annual flu shot.

“Every year, you need to go to get your flu vaccine,” Bourla said. “It’s going to be the same with COVID. In a year, you will have to go and get your annual shot for Covid to be protected.”

Dr. Anthony Fauci has already previewed the possibility of coronavirus booster shots, explaining people “very well may need to get booster shots to keep up the level of protection.”

SNIP